Page 221 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

General discussion and future perspectives
59. Fernandez A, Meechan DW, Karpinski BA, et al. Mitochondrial Dysfunction Leads to Cortical
Under-Connectivity and Cognitive Impairment. Neuron. Jun 19 2019;102(6):1127-1142.e3.
doi:10.1016/j.neuron.2019.04.013
60. Bose A, Beal MF. Mitochondrial dysfunction in Parkinson’s disease. J Neurochem. Oct 2016;139
Suppl 1:216-231. doi:10.1111/jnc.13731
61. Kolar D, Krajcovic B, Kleteckova L, Kuncicka D, Vales K, Brozka H. Review: Genes Involved
in Mitochondrial Physiology Within 22q11.2 Deleted Region and Their Relevance to
Schizophrenia. Schizophr Bull. Jun 28 2023;doi:10.1093/schbul/sbad066
62. Boot E, Óskarsdóttir S, Loo JCY, et al. Updated clinical practice recommendations for managing
adults with 22q11.2 deletion syndrome. Genet Med. Mar 2023;25(3):100344. doi:10.1016/j.
gim.2022.11.012
63. Zarchi O, Attias J, Raveh E, Basel-Vanagaite L, Saporta L, Gothelf D. A comparative study
of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and
Williams (7q11.23 deletion) syndromes. J Pediatr. Feb 2011;158(2):301-6. doi:10.1016/j.
jpeds.2010.07.056
64. Forbes BJ, Binenbaum G, Edmond JC, DeLarato N, McDonald-McGinn DM, Zackai EH. Ocular
findings in the chromosome 22q11.2 deletion syndrome. J aapos. Apr 2007;11(2):179-82.
doi:10.1016/j.jaapos.2006.08.006
65. Van Eynde C, Swillen A, Lambeens E, et al. Prevalence and Nature of Hearing Loss in 22q11.2
Deletion Syndrome. J Speech Lang Hear Res. Jun 1 2016;59(3):583-9. doi:10.1044/2015_
jslhr-h-15-0098
66. Dykens EM. Aging in rare intellectual disability syndromes. Developmental Disabilities Research
Reviews. 2013/08/01 2013;18(1):75-83.
67. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited
metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J
Rare Dis. Apr 12 2021;16(1):170. doi:10.1186/s13023-021-01727-2
68. Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A. Movement Disorders in Treatable Inborn
Errors of Metabolism. Mov Disord. May 2019;34(5):598-613. doi:10.1002/mds.27568
69. Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY. Everolimus for the treatment of
refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives.
Ther Clin Risk Manag. 2019;15:951-955. doi:10.2147/tcrm.S145630
70. Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M. Adult-onset phenylketonuria
with rapidly progressive dementia and parkinsonism. Neurocase. Jun 2016;22(3):273-5. doi:10
.1080/13554794.2016.1142567
71. Hendrix JA, Amon A, Abbeduto L, et al. Opportunities, barriers, and recommendations in down
syndrome research. Transl Sci Rare Dis. 2021;5(3-4):99-129. doi:10.3233/trd-200090
72. Meuwese-Jongejeugd A, Verschuure H, Evenhuis HM. Hearing aids: expectations and
satisfaction of people with an intellectual disability, a descriptive pilot study. J Intellect Disabil
Res. Nov 2007;51(Pt 11):913-22. doi:10.1111/j.1365-2788.2007.00952.x
73. Zinkstok JR, Boot E, Bassett AS, et al. Neurobiological perspective of 22q11.2 deletion
syndrome. Lancet Psychiatry. Nov 2019;6(11):951-960. doi:10.1016/s2215-0366(19)30076-8
74. Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer’s disease
associated with Down syndrome: a genetic form of dementia. Lancet Neurol. Nov
2021;20(11):930-942. doi:10.1016/s1474-4422(21)00245-3
75. Starr JM. Ageing and epigenetics: linking neurodevelopmental and neurodegenerative
disorders. Dev Med Child Neurol. Oct 2019;61(10):1134-1138. doi:10.1111/dmcn.14210
76. Snihirova Y, Linden DEJ, van Amelsvoort T, van der Meer D. Environmental Influences on the
Relation between the 22q11.2 Deletion Syndrome and Mental Health: A Literature Review.
Genes (Basel). Nov 2 2022;13(11)doi:10.3390/genes13112003
77. Bach S, Shovlin S, Moriarty M, Bardoni B, Tropea D. Rett Syndrome and Fragile X Syndrome:
Different Etiology With Common Molecular Dysfunctions. Front Cell Neurosci. 2021;15:764761.
doi:10.3389/fncel.2021.764761
8
219